Imricor Medical Systems, Inc. (IMR.AX)
AUD 0.96
(-2.05%)
AUD 0.96
(-2.05%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 15.7 Million AUD | 249.7% |
| 2022 | 4.49 Million USD | 158.4% |
| 2021 | 1.73 Million AUD | 25.38% |
| 2020 | 1.38 Million AUD | 791.73% |
| 2019 | 155.42 Thousand AUD | -90.87% |
| 2018 | 1.7 Million AUD | -43.0% |
| 2017 | 2.98 Million AUD | 30.95% |
| 2016 | 2.28 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 8.16 Million USD | 15.4% |
| 2024 Q1 | 8.16 Million USD | -21.67% |
| 2023 Q1 | 5.65 Million USD | 26.04% |
| 2023 FY | 15.7 Million AUD | 249.7% |
| 2023 Q3 | 9.98 Million USD | 76.49% |
| 2023 Q2 | 5.65 Million USD | 0.0% |
| 2023 Q4 | 10.42 Million USD | 4.34% |
| 2022 Q4 | 4.49 Million USD | 25.46% |
| 2022 FY | 4.49 Million USD | 158.4% |
| 2022 Q3 | 3.57 Million USD | 126.13% |
| 2022 Q1 | 1.58 Million USD | -8.92% |
| 2022 Q2 | 1.58 Million USD | 0.0% |
| 2021 Q3 | 1.21 Million USD | 12.61% |
| 2021 FY | 1.73 Million AUD | 25.38% |
| 2021 Q1 | 1.08 Million USD | -39.85% |
| 2021 Q4 | 1.73 Million AUD | 42.55% |
| 2021 Q2 | 1.08 Million USD | 0.0% |
| 2020 Q4 | 1.79 Million AUD | -2.04% |
| 2020 FY | 1.38 Million AUD | 791.73% |
| 2020 Q1 | 2.18 Million USD | 48.37% |
| 2020 Q2 | 2.18 Million USD | 0.0% |
| 2020 Q3 | 1.83 Million USD | -15.83% |
| 2019 Q4 | 1.47 Million USD | 0.0% |
| 2019 FY | 155.42 Thousand AUD | -90.87% |
| 2019 Q3 | 1.47 Million USD | -88.78% |
| 2019 Q2 | 13.1 Million USD | 0.0% |
| 2019 Q1 | 13.1 Million USD | 36.59% |
| 2018 FY | 1.7 Million AUD | -43.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | 9.59 Million USD | 0.0% |
| 2018 Q4 | 9.59 Million USD | 0.0% |
| 2017 FY | 2.98 Million AUD | 30.95% |
| 2016 FY | 2.28 Million AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | -206.633% |
| Adherium Limited | 93.2 Thousand AUD | -16746.189% |
| Aroa Biosurgery Limited | 6.81 Million AUD | -130.337% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -18444.337% |
| Anteris Technologies Ltd | 2.33 Million AUD | -573.045% |
| Control Bionics Limited | 961.73 Thousand AUD | -1532.616% |
| CardieX Limited | 3.22 Million AUD | -386.453% |
| Compumedics Limited | 6.97 Million AUD | -125.046% |
| Cochlear Limited | 243.7 Million AUD | 93.557% |
| CleanSpace Holdings Limited | 3.44 Million AUD | -355.604% |
| Cyclopharm Limited | 4.22 Million AUD | -271.431% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | -441.374% |
| Nova Eye Medical Limited | 3.34 Million AUD | -368.841% |
| HeraMED Limited | 260.65 Thousand AUD | -5923.836% |
| ImpediMed Limited | 1.14 Million AUD | -1273.709% |
| InhaleRx Limited | 560.27 Thousand AUD | -2702.461% |
| LBT Innovations Limited | 1.74 Million AUD | -800.831% |
| Micro-X Limited | 4.05 Million AUD | -287.213% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -22117.413% |
| PolyNovo Limited | 15.38 Million AUD | -2.09% |
| Respiri Limited | 1.17 Million AUD | -1234.522% |
| SomnoMed Limited | 1.01 Million AUD | -1445.402% |
| Universal Biosensors, Inc. | 4.97 Million AUD | -215.831% |
| Uscom Limited | 989.27 Thousand AUD | -1487.167% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -4930.014% |